Treatment for Anti-GBM Antibody Disease
When it comes to treating Anti-GBM Antibody Disease, the approach can vary depending on the timing and severity of the condition. One common method involves the use of medication that suppresses the immune system. By doing so, the production of anti-GBM antibodies can be curbed, leading to a reduction in inflammation.
Another treatment option is plasmapheresis, also known as plasma exchange. This therapy involves using a machine to filter the blood and remove the harmful antibodies. Typically, plasmapheresis is performed over a period of a few weeks.
In some cases, patients may need to continue taking immunosuppressive drugs for several months after undergoing treatment, depending on how they respond to the therapy.
Prognosis and Complications
Reoccurrence of Goodpasture syndrome is possible in certain cases, even after receiving successful treatment. However, with the utilization of effective therapies and early intervention, the five-year survival rate surpasses 80 percent. Fortunately, less than 30 percent of individuals who have recovered from Goodpasture syndrome require long-term dialysis. In severe instances, a kidney transplant may be necessary for the patient.